Improvement of heart iron with preserved patterns of iron store by CMR-guided chelation therapy

被引:39
作者
Meloni, Antonella [1 ]
Positano, Vincenzo [1 ]
Ruffo, Giovan Battista [2 ]
Spasiano, Anna [3 ]
D'Ascola, Domenico Giuseppe [4 ]
Peluso, Angelo [5 ]
Keilberg, Petra [1 ]
Restaino, Gennaro [6 ]
Valeri, Gianluca [7 ]
Renne, Stefania [8 ]
Midiri, Massimo [9 ]
Pepe, Alessia [1 ]
机构
[1] Fdn G Monasterio CNR Reg Toscana, CMR Unit, Area Ric S Cataldo, I-56124 Pisa, Italy
[2] Osped Civ, UOC Ematol Talassemia, Palermo, Italy
[3] AORN Cardarelli, UOSD Ctr Microcitemie, Naples, Italy
[4] AO Bianchi Melacrino Morelli, UO Microcitemie, Reggio Di Calabria, Italy
[5] Presidio Osped Cent, Microcitemia Azienda Unita Sanit Locale TA 1, Taranto, Italy
[6] Univ Cattolica Sacro Cuore, Ctr Ric & Formaz Alta Tecnol Sci Biomed Giovanni, Campobasso, Italy
[7] Azienda Osped Univ, Osped Riuniti Umberto I Lancisi Salesi, Dipartimento Radiol, Ancona, Italy
[8] Struttura Complessa Cardioradiol UTIC, Lamezia Terme, Italy
[9] Policlin Paolo Giaccone, Ist Radiol, Palermo, Italy
关键词
Cardiac magnetic resonance; Myocardial iron overload; Preferential pattern; Thalassaemia major; T2-ASTERISK-CARDIOVASCULAR MAGNETIC-RESONANCE; THALASSEMIA MAJOR PATIENTS; MYOCARDIAL IRON; CARDIAC IRON; HEPATIC IRON; IN-VIVO; DEFERIPRONE; EFFICACY; DESFERRIOXAMINE; DEFEROXAMINE;
D O I
10.1093/ehjci/jeu191
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims T*(2) multislice multiecho cardiac magnetic resonance (CMR) allows quantification of the segmental distribution of myocardial iron overload (MIO). We evaluated whether a preferential pattern MIO was preserved between two CMR scans in regularly chelated thalassaemia major (TM) patients. Methods and results We evaluated prospectively 259 TM patients enrolled in the MIO in Thalassaemia (MIOT) network with a CMR follow-up (FU) study at 18 +/- 3 months and significant MIO at baseline. The T*(2) in the 16 segments and the global value were calculated. Four main circumferential regions (anterior, septal, inferior and lateral) were defined. We identified two groups: severe (n = 80, global T*(2) <10 ms) and mild-moderate MIO (n = 179, global T*(2) = 10-26 ms). Based on the CMR reports, 56.4% of patients changed the chelation regimen. For each group, there was a significant improvement in the global heart as well as in regional T*(2) values (P < 0.0001). At the baseline, the mean T*(2) value over the anterior region was significantly lower than the values over the other regions, and the mean T*(2) over the inferior region was significantly lower than the values over the septal and the lateral regions. The same pattern was present at the FU, with a little difference for patients with mild-moderate MIO. Conclusion A preferential pattern of iron store in anterior and inferior regions was present at both CMRs, with an increment of T*(2) values at FU due to a baseline CMR-guided chelation therapy. The anterior region seems the region in which the iron accumulates first and is removed later.
引用
收藏
页码:325 / 334
页数:10
相关论文
共 32 条
[1]   Simulation Study of Susceptibility Gradients Leading to Focal Myocardial Signal Loss [J].
Anderson, Douglas J. ;
Dendy, Jeffrey M. ;
Paschal, Cynthia B. .
JOURNAL OF MAGNETIC RESONANCE IMAGING, 2008, 28 (06) :1402-1408
[2]   Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload [J].
Anderson, LJ ;
Holden, S ;
Davis, B ;
Prescott, E ;
Charrier, CC ;
Bunce, NH ;
Firmin, DN ;
Wonke, B ;
Porter, J ;
Walker, JM ;
Pennell, DJ .
EUROPEAN HEART JOURNAL, 2001, 22 (23) :2171-2179
[3]   Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: a prospective study using T2*cardiovascular magnetic resonance [J].
Anderson, LJ ;
Westwood, MA ;
Holden, S ;
Davis, B ;
Prescott, E ;
Wonke, B ;
Porter, JB ;
Walker, JM ;
Pennell, DJ .
BRITISH JOURNAL OF HAEMATOLOGY, 2004, 127 (03) :348-355
[4]  
[Anonymous], METABOLIC MOL BASIS
[5]   The efficacy of iron chelator regimes in reducing cardiac and hepatic iron in patients with thalassaemia major: a clinical observational study [J].
Berdoukas, Vasilios ;
Chouliaras, Giorgos ;
Moraitis, Panagiotis ;
Zannikos, Kirykos ;
Berdoussi, Eleni ;
Ladis, Vassilios .
JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE, 2009, 11
[6]   On T2*Magnetic Resonance and Cardiac Iron [J].
Carpenter, John-Paul ;
He, Taigang ;
Kirk, Paul ;
Roughton, Michael ;
Anderson, Lisa J. ;
de Noronha, Sofia V. ;
Sheppard, Mary N. ;
Porter, John B. ;
Walker, J. Malcolm ;
Wood, John C. ;
Galanello, Renzo ;
Forni, Gianluca ;
Catani, Gualtiero ;
Matta, Gildo ;
Fucharoen, Suthat ;
Fleming, Adam ;
House, Michael J. ;
Black, Greg ;
Firmin, David N. ;
St Pierre, Timothy G. ;
Pennell, Dudley J. .
CIRCULATION, 2011, 123 (14) :1519-1528
[7]   Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart - A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association [J].
Cerqueira, MD ;
Weissman, NJ ;
Dilsizian, V ;
Jacobs, AK ;
Kaul, S ;
Laskey, WK ;
Pennell, DJ ;
Rumberger, JA ;
Ryan, T ;
Verani, MS .
CIRCULATION, 2002, 105 (04) :539-542
[8]   MRI detects myocardial iron in the human heart [J].
Ghugre, Nilesh R. ;
Enriquez, Cathleen M. ;
Gonzalez, Ignacio ;
Nelson, Marvin D., Jr. ;
Coates, Thomas D. ;
Wood, John C. .
MAGNETIC RESONANCE IN MEDICINE, 2006, 56 (03) :681-686
[9]  
Gossuin Y, 2000, MAGN RESON MED, V43, P237, DOI 10.1002/(SICI)1522-2594(200002)43:2<237::AID-MRM10>3.0.CO
[10]  
2-5